Related Experiment Video
Updated: Aug 10, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
[Reliable and new aspects of insulin therapy]
14. Medizinische Klinik des Klinikums Nürnberg, Universität Erlangen-Nürnberg.
Abstract:
New findings concerning the dynamic of insulin secretion, insulin action and pharmacokinetics of insulin preparations have caused a complete change of insulin therapy in diabetes mellitus (basis-bolus-concept). At the same time, the discrepancy between insulin substitution and physiologic conditions becomes evident. Even the use of human insulin or the development of insulin-pens and -pumps does not influence that fact. From the beginning of insulin therapy till now the subcutaneous injection of insulin is the safest and easiest way of application. By means of modified insulins (bioengineering) the physico-chemical process of insulin resorption could be elucidated in the last 4 years. In clinical experiments the intraperitoneal and nasal insulin administration is tested extensively. In the field of the intensified insulin therapy including near normoglycemic therapeutic goals the awareness of hypoglycemia is of particular importance.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into rapid-acting...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Oral Hypoglycemic Agents: Glinides

